After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Acrivon Therapeutics Inc is $51.27M. A total of 0.81 million shares were traded on the day, compared to an average of 1.27M shares.
In the most recent transaction, PERCEPTIVE ADVISORS LLC sold 437,881 shares of ACRV for 1.41 per share on Apr 30 ’25. After the transaction, the 10% Owner now owns 3,403,025 company shares. In a previous transaction on May 01 ’25, PERCEPTIVE ADVISORS LLC sold 298,886 shares at 1.34 per share. ACRV shares that 10% Owner owns now total 3,104,139.
Among the insiders who sold shares, PERCEPTIVE ADVISORS LLC disposed of 1,054,669 shares on Apr 25 ’25 at a per-share price of $1.95. This resulted in the 10% Owner holding 4,306,189 shares of ACRV after the transaction. In another insider transaction, PERCEPTIVE ADVISORS LLC sold 250,000 shares at $1.41 per share on Apr 29 ’25. Company shares held by the 10% Owner now total 3,840,906.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, ACRV has a high of $10.00 and a low of $1.05.
As of this writing, ACRV has an earnings estimate of -$0.58 per share for the current quarter. EPS was calculated based on a consensus of 7.0 estimates, with a high estimate of -$0.49 per share and a lower estimate of -$0.73. The company reported an EPS of -$0.59 in the last quarter
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. ACRV’s latest balance sheet shows that the firm has $99.60M in Cash & Short Term Investments as of fiscal 2021. There were $5.63M in debt and $2.91M in liabilities at the time. Its Book Value Per Share was $4.55, while its Total Shareholder’s Equity was -$23.81M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ACRV is Buy with a score of 4.60.
